These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21659768)

  • 1. Translating experimental diabetic nephropathy studies from mice to men.
    Breyer MD
    Contrib Nephrol; 2011; 170():156-164. PubMed ID: 21659768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting Experimental Models of Diabetic Nephropathy.
    Giralt-López A; Molina-Van den Bosch M; Vergara A; García-Carro C; Seron D; Jacobs-Cachá C; Soler MJ
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32438732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy.
    Wysocki J; Ye M; Khattab AM; Fogo A; Martin A; David NV; Kanwar Y; Osborn M; Batlle D
    Kidney Int; 2017 Jun; 91(6):1336-1346. PubMed ID: 27927599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between structural and functional changes to the kidney in diabetic humans and mice.
    Powell DW; Kenagy DN; Zheng S; Coventry SC; Xu J; Cai L; Carlson EC; Epstein PN
    Life Sci; 2013 Aug; 93(7):257-64. PubMed ID: 23800643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy.
    Tchekneva EE; Rinchik EM; Polosukhina D; Davis LS; Kadkina V; Mohamed Y; Dunn SR; Sharma K; Qi Z; Fogo AB; Breyer MD
    J Am Soc Nephrol; 2007 Jan; 18(1):103-12. PubMed ID: 17151334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pronounced kidney hypoxia precedes albuminuria in type 1 diabetic mice.
    Franzén S; Pihl L; Khan N; Gustafsson H; Palm F
    Am J Physiol Renal Physiol; 2016 May; 310(9):F807-9. PubMed ID: 26936871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the Hp 2-2 diabetic mouse model a good model to study diabetic nephropathy?
    Nakhoul F; Nakhoul N; Asleh R; Miller-Lotan R; Levy AP
    Diabetes Res Clin Pract; 2013 Jun; 100(3):289-97. PubMed ID: 23490597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium/glucose cotransporter 2 inhibitors and prevention of diabetic nephropathy: targeting the renal tubule in diabetes.
    De Nicola L; Gabbai FB; Liberti ME; Sagliocca A; Conte G; Minutolo R
    Am J Kidney Dis; 2014 Jul; 64(1):16-24. PubMed ID: 24673844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A more tubulocentric view of diabetic kidney disease.
    Zeni L; Norden AGW; Cancarini G; Unwin RJ
    J Nephrol; 2017 Dec; 30(6):701-717. PubMed ID: 28840540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Endothelial Cell Injury Marker Cd146 Correlates with Disease Severity and Predicts the Renal Outcomes in Patients with Diabetic Nephropathy.
    Fan Y; Fei Y; Zheng L; Wang J; Xiao W; Wen J; Xu Y; Wang Y; He L; Guan J; Wei J; He JC; Wang N
    Cell Physiol Biochem; 2018; 48(1):63-74. PubMed ID: 30001528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Changes in Measured Glomerular Filtration Rate, Renal Fibrosis and Biomarkers in a Rat Model of Type 2 Diabetic Nephropathy.
    Su Z; Widomski D; Ma J; Namovic M; Nikkel A; Leys L; Olson L; Salte K; Donnelly-Roberts D; Esbenshade T; McGaraughty S
    Am J Nephrol; 2016; 44(5):339-353. PubMed ID: 27736813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug discovery for diabetic nephropathy: trying the leap from mouse to man.
    Breyer MD
    Semin Nephrol; 2012 Sep; 32(5):445-51. PubMed ID: 23062985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinicopathological characteristics of diabetic nephropathy and non-diabetic renal diseases in diabetic patients].
    Xu J; Hu XF; Huang W; Shen PY; Zhang W; Ren H; Li X; Wang WM; Chen N; Pan XX
    Zhonghua Nei Ke Za Zhi; 2017 Dec; 56(12):924-929. PubMed ID: 29202533
    [No Abstract]   [Full Text] [Related]  

  • 15. Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers.
    Ivory SE; Packham DK; Reutens AT; Wolfe R; Rohde RD; Lewis J; Atkins RC;
    Nephrology (Carlton); 2013 Jul; 18(7):516-24. PubMed ID: 23506627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy.
    Mifsud S; Kelly DJ; Qi W; Zhang Y; Pollock CA; Wilkinson-Berka JL; Gilbert RE
    Nephron Physiol; 2003; 95(4):p83-91. PubMed ID: 14694265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albuminuria and reduced glomerular filtration rate for predicting the renal outcomes in type 2 diabetic patients.
    Tanaka N; Babazono T; Takagi M; Yoshida N; Toya K; Nyumura I; Hanai K; Uchigata Y
    Nephrology (Carlton); 2015 Aug; 20(8):531-8. PubMed ID: 25773273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes.
    Kanetsuna Y; Hirano K; Nagata M; Gannon MA; Takahashi K; Harris RC; Breyer MD; Takahashi T
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1315-22. PubMed ID: 16705146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
    Ge J; Miao JJ; Sun XY; Yu JY
    J Ethnopharmacol; 2016 Aug; 189():238-49. PubMed ID: 27224243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic Nephropathy: A Comparison of the Clinical and Pathological Features between the CKD Risk Classification and the Classification of Diabetic Nephropathy 2014 in Japan.
    Furuichi K; Shimizu M; Hara A; Toyama T; Wada T
    Intern Med; 2018 Dec; 57(23):3345-3350. PubMed ID: 30101924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.